Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells-Reference-Cited by-同舟云学术

Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells

Published:2017-07 Issue: Volume:Volume 10 Page:3313-3327
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Woitok Mira,Klose Diana,Di Fiore Stefano,Richter Wolfgang,Stein Christoph,Gresch Gerrit,Grieger Elena,Barth Stefan^ORCID,Fischer Rainer,Kolberg Katharina,Niesen Judith

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Investigation into the In Vitro Targeted Killing of CD44-Expressing Triple-Negative Breast Cancer Cells Using Recombinant Photoimmunotherapeutics Compared to Auristatin-F-Based Antibody-Drug Conjugates;Molecular Pharmaceutics;2024-07-24

2. Design and Evaluation of a Humanized Anti-EGFR huscFv Antibody Fragment in Combination With Metformin in A549 CellsIn Vitro;Anticancer Research;2024-04-27

3. CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate;Journal of Cancer Research and Clinical Oncology;2023-07-11

4. Click Chemistry-Generated Auristatin F–Linker–Benzylguanine for a SNAP-Tag-Based Recombinant Antibody–Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells;ACS Omega;2023-01-17

5. Modification of bacterial microcompartments with target biomolecules via post-translational SpyTagging;Materials Advances;2023